Bladder Cancer Advocacy Network Now Accepting Applications for 2019 Research AwardsCall for Research Proposals
05 déc. 2018 07h05 HE
|
Bladder Cancer Advocacy Network (BCAN)
Bethesda, Maryland, Dec. 05, 2018 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) is seeking applicants for its 2019 Bladder Cancer Research Innovation Award which will fund one...
CicloMed Announces ASCO 2018 Presentation on Clinical Trial for Ciclopirox Prodrug, Under Development for Bladder Cancer
31 mai 2018 09h30 HE
|
CicloMed LLC
KANSAS CITY, Mo., May 31, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced the presentation of a scientific poster...
CicloMed Announces Presentation of Preclinical Evidence for its Bladder Cancer Agent at AACR 2018 Meeting
12 avr. 2018 09h00 HE
|
CicloMed LLC
KANSAS CITY, Mo., April 12, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced the presentation of preclinical evidence...
Imagin Medical Announces Private Placement
03 avr. 2018 08h00 HE
|
Imagin Medical Inc.
Imagin Medical is the developer of the ultrasensitive i/Blue Imaging System that will establish a new standard of care in detecting cancers and visualizing the surgical field in minimally invasive...
CicloMed Announces First Patient Dosed with Ciclopirox Prodrug in Phase I Trial in Patients with Advanced Solid Tumors
28 févr. 2018 10h08 HE
|
CicloMed LLC
KANSAS CITY, Mo., Feb. 28, 2018 (GLOBE NEWSWIRE) -- CicloMed LLC, a biotechnology company developing novel treatments for bladder cancer, today announced that the first patient has been dosed in a...
Napoli Shkolnik PLLC Files A Class Action Lawsuit For Love Canal, New York
16 févr. 2018 16h31 HE
|
Napoli Shkolnik PLLC
NEW YORK, NY--(Marketwired - February 16, 2018) - Napoli Shkolnik has filed a class action lawsuit against the City of Niagara Falls, the Niagara Falls Water Board, Occidental Petroleum Corporation...
CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder Cancer
11 oct. 2017 09h00 HE
|
CicloMed LLC
KANSAS CITY, Mo., Oct. 11, 2017 (GLOBE NEWSWIRE) -- CicloMed LLC announced today that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was...
American Health Council Names Luay Susan, M.D., to Physician Board
25 janv. 2017 11h32 HE
|
American Health Council
NEW YORK, Jan. 25, 2017 (GLOBE NEWSWIRE) -- Dr. Luay Susan, Staff Urologist at the Cleveland Clinic, has been selected to join the Physician Board at the American Health Council. He will be sharing...
FDA Approves New Bladder Cancer Treatment
18 mai 2016 15h02 HE
|
Bladder Cancer Advocacy Network
BETHESDA, Md., May 18, 2016 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) applauds the U.S. Food and Drug Administration (FDA) approval of an innovative, first-of-its-kind bladder...
ArQule Announces Orphan Drug Designation in Cholangiocarcinoma and Clinical Update for ARQ 087
15 déc. 2015 07h30 HE
|
ArQule, Inc.
Orphan drug designation marks significant regulatory milestone for phase 2 trialAdditional response in phase 1b further validates development for ARQ 087 in cancers with FGFR2 genetic alterations ...